TL;DR: PNOĒ does not publish a price list we can verify, which is normal for Healthcare companies at this stage. Below: what we can confirm, how to get a real quote, and 8 comparable tools to benchmark the number against.
What is verifiable about PNOĒ pricing, how to get a real quote, and 8 comparable tools to price it against.
Last verified:
Not in any source we can verify. PNOĒ is a Y Combinator-backed Healthcare company from the Winter 2019 batch, and companies at this stage usually quote per customer rather than publish rate cards. We will not guess at a number — anything quoted elsewhere without a source is guesswork too. The company profile we work from is the Y Combinator listing; the current figure has to come from PNOĒ directly.
These are the closest comparable tools, matched on what PNOĒ actually does. Price each one alongside it — stage and team size are a reasonable proxy for where a vendor sits on price.
| Compare against | What it does | Stage | Team |
|---|---|---|---|
| Docbot | — | YC Winter 2019 | — |
| Biocogniv | — | YC Summer 2020 | 6 |
| Bristle | At-home oral health testing, coaching & care | YC Winter 2021 | 6 |
| Instapath Inc. | We built the world's first automated digital pathology lab. | YC Winter 2019 | 6 |
| Zen | Posture correction software | YC Summer 2021 | — |
| Furmacy | Digital e-prescribing software for veterinarians. | YC Winter 2021 | 5 |
| Care GP | AI agents to run primary healthcare operations | YC Summer 2026 | 10 |
| Comet Health | Digital platform for pelvic floor physical therapy | YC Summer 2021 | 3 |
That depends on a number we cannot see, so judge it on what we can: PNOĒ is currently Active with a team of around 70. A small team means faster support and more negotiating room, but more risk of the product changing direction. A larger or public vendor costs more and moves slower. If price is the deciding factor, the earlier-batch companies in the table are usually the ones still competing on it.
See all PNOĒ alternatives compared →
Built by LemStudio
Loading interactive view…